USP 795/797/800 Compounding Standards
Follow beyond-use dating, aseptic technique for sterile compounding, and hazardous drug handling per USP 800.
USP 795/797/800 Compounding Standards
Master USP compounding standards with free flashcards and spaced repetition to build lasting knowledge. This lesson covers USP <795> for non-sterile compounding, USP <797> for sterile preparations, and USP <800> for hazardous drug handlingβessential standards for NAPLEX success and safe pharmacy practice.
Welcome to Compounding Standards Mastery π§ͺ
The United States Pharmacopeia (USP) establishes critical standards that govern how pharmacies compound medications. These three chapters form the cornerstone of safe compounding practice:
- USP <795>: Non-sterile compounding (creams, capsules, solutions)
- USP <797>: Sterile compounding (IV admixtures, injections, ophthalmics)
- USP <800>: Hazardous drug handling (chemotherapy, hormones)
Understanding these standards isn't just about passing the NAPLEXβit's about protecting patients and staff from contamination, infection, and exposure to dangerous substances. Let's break down each chapter systematically.
Core Concept 1: USP <795> β Non-Sterile Compounding π
USP <795> governs the preparation of non-sterile compounded preparations (CSPs) that won't be administered via injection or into sterile body cavities.
Key Components of USP <795>
1. Beyond-Use Dating (BUD) β°
BUD is the date/time after which a compounded preparation should NOT be used. It's determined by:
| Dosage Form | Storage Condition | Maximum BUD |
|---|---|---|
| Non-aqueous formulations (ointments, capsules) |
Room temperature or refrigerated | 180 days or time to expiration of shortest-dated ingredient (whichever is earlier) |
| Water-containing oral formulations (solutions, suspensions) |
Room temperature | 14 days |
| Water-containing topicals/dermals/mucosals | Room temperature | 30 days |
π‘ Memory Device - "The 14/30/180 Rule":
- 14 days: Water-based oral (you drink it)
- 30 days: Water-based topical (you touch it)
- 180 days: Non-aqueous (no water, longer shelf life)
β οΈ Important: These are MAXIMUM BUDs assuming proper storage and ingredients. Use stability data when available!
2. Facilities and Equipment Requirements
- Designated compounding area: Separate from dispensing, adequate space and lighting
- Calibrated equipment: Balances accurate to Β±0.01g for prescription balances
- Master formulation record: Recipe with ingredients, quantities, equipment, BUD calculation
- Compounding record: Batch-specific documentation of who made what, when, and lot numbers
3. Personnel Training and Hygiene π¨βπ¬
- Hand hygiene: Wash hands before and during compounding
- Garbing: Clean lab coat, hair covering when necessary
- Training documentation: Annual competency verification
- Personal protective equipment (PPE): Gloves, masks as appropriate
4. Quality Assurance Activities
- Ingredient verification: Check identity and quality
- Visual inspection: Color, clarity, consistency
- Documentation review: Ensure calculations are correct
- Cleaning logs: Document equipment and area cleaning
Core Concept 2: USP <797> β Sterile Compounding π
USP <797> governs sterile preparations that will be administered parenterally (IV, IM, SC) or to sterile body sites (eyes, epidural space).
Risk Categories in USP <797>
Sterile preparations are classified by contamination risk:
| Risk Category | Definition | Examples | Room Temp BUD | Refrigerated BUD | Frozen BUD |
|---|---|---|---|---|---|
| Category 1 | Simple aseptic preparations using β€3 sterile products, β€2 entries per container, single patient use | IV antibiotic in minibag from vial | 12 hours | 24 hours | 45 days |
| Category 2 | Multiple individual doses combined, longer compounding times, >3 products or >2 entries | TPN, batch preparations | 4 hours (if no ISO 5 testing) 24 hours (with ISO 5) |
9 days (with ISO 5) | 45 days (with ISO 5) |
| Category 3 | Preparations from non-sterile ingredients requiring sterilization | Compounding from bulk powder with terminal sterilization | 3 days | 9 days | 45 days |
π‘ Memory Device - "1-2-3 Complexity":
- Category 1: Simple (1 = easy, basic IV prep)
- Category 2: Medium (2 = more complex, TPNs)
- Category 3: Challenging (3 = hardest, start non-sterile)
Environmental Controls π’
Primary Engineering Control (PEC)
The ISO Class 5 environment where compounding actually occurs:
- Laminar airflow workbench (LAFW): Horizontal or vertical flow
- Biological safety cabinet (BSC): For hazardous drugs
- Compounding aseptic isolator (CAI): Enclosed system
- Compounding aseptic containment isolator (CACI): For hazardous drugs in isolation
Secondary Engineering Control (SEC)
The room containing the PEC:
- Buffer area/room: ISO Class 7 or better, contains the PEC
- Ante-area/room: ISO Class 8 or better, for hand hygiene and garbing
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ β ANTE-AREA (ISO 8) β β πͺ Entry β π§Ό Hand washing β π Garbing β β β β β βββββββββββββββββββββββββββββββββββββββββββββββββββ β β β BUFFER ROOM (ISO 7) β β β β β β β β ββββββββββββββββββββββββββββββββ β β β β β PEC (ISO 5) β β β β β β π§ͺ Actual Compounding β β β β β β Laminar Flow Hood β β β β β ββββββββββββββββββββββββββββββββ β β β β β β β βββββββββββββββββββββββββββββββββββββββββββββββββββ β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ Air Quality: ISO 5 (cleanest) < ISO 7 < ISO 8 Pressure: Positive β Prevents contamination entry
Garbing Requirements for Sterile Compounding π¨ββοΈ
Order matters! Follow this sequence:
- Remove personal items (jewelry, watches)
- Don shoe covers
- Don head/facial hair covers
- Perform hand hygiene (wash with soap/water)
- Don gown (non-shedding)
- Don face mask
- Enter buffer room
- Perform antiseptic hand cleansing (alcohol-based sanitizer)
- Don sterile gloves
π‘ Mnemonic - "SHHGG-MHG": Shoes, Head, Hands, Gown, (enter) β Mask (already on), Hands (antiseptic), Gloves
Personnel Competency Assessment π
Initial training must include:
- Written test: Understanding of principles
- Media fill test (process simulation): Compound with tryptic soy broth (TSB) instead of drug, incubate 14 days
- Must pass 3 consecutive media fills
- Zero growth = Pass
Ongoing competency:
- Annual media fill for low/medium risk
- Semi-annual media fill for high risk
- Annual written assessment
Core Concept 3: USP <800> β Hazardous Drug Handling β’οΈ
USP <800> protects healthcare personnel from exposure to hazardous drugs (HDs) that pose risks including carcinogenicity, teratogenicity, reproductive toxicity, organ toxicity, and genotoxicity.
What Are Hazardous Drugs?
HDs are classified into three groups:
| Group | Description | Examples |
|---|---|---|
| Group 1 | Antineoplastic drugs | Cyclophosphamide, doxorubicin, methotrexate, fluorouracil |
| Group 2 | Non-antineoplastic HDs on NIOSH list | Finasteride, estradiol, testosterone, ganciclovir, ribavirin |
| Group 3 | Drugs with reproductive risk (in humans) | Certain antivirals, hormones during pregnancy/lactation |
NIOSH (National Institute for Occupational Safety and Health) maintains the definitive list of hazardous drugs, updated regularly.
Engineering Controls for Hazardous Drugs π‘οΈ
Containment Primary Engineering Controls (C-PEC)
HDs must be compounded in:
- Class II or III Biological Safety Cabinet (BSC)
- Compounding Aseptic Containment Isolator (CACI)
These provide:
- Product protection (sterility)
- Personnel protection (containment)
- Environmental protection (filtered exhaust)
Key Features:
- Negative pressure relative to surrounding area
- Externally vented (exhausted outside building, not recirculated)
- HEPA filtration on exhaust
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ β HAZARDOUS DRUG COMPOUNDING SUITE β β β β ββββββββββββββββββββββββββ ββββββββββββββββββββ β β β ANTE-ROOM (ISO 7-8) β β BUFFER ROOM β β β β β’ Unpacking ββββββ (Negative β β β β β’ Deactivation β β Pressure) β β β β β’ Decontamination β β βββββββββββββββ β β β ββββββββββββββββββββββββββ β β C-PEC β β β β β β β (BSC/ β β β β Normal pressure β β CACI) β β β β β βββββββββββββββ β β β β β β β β β HEPA filter β β β β β β β β β π¬οΈ Vented out β β β ββββββββββββββββββββ β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
Personal Protective Equipment (PPE) for HDs π§€
Receiving/Unpacking/Transporting:
- Chemotherapy gloves (ASTM D6978-05 tested)
- Gown
Compounding:
- Double chemotherapy gloves (change outer every 30 minutes)
- Non-shedding gown with closed front, tight cuffs
- Hair/beard covers
- Shoe covers
- Respiratory protection if risk of airborne exposure
- Face shield if splash risk
Administering:
- Single chemo gloves
- Gown
- Face/eye protection if splash risk
π‘ Critical Detail: Standard latex/nitrile exam gloves are NOT sufficientβmust be chemotherapy-tested gloves!
Spill Management π¨
Small spill (<5 mL or 5 g):
- Restrict access
- Don full PPE
- Use spill kit:
- Absorbent pads
- HD disposal bags
- Deactivating/cleaning agents
- Clean from outside toward center
- Dispose in HD waste
Large spill (>5 mL or 5 g):
- Evacuate area
- Call trained spill team
- May require environmental services
Decontamination and Cleaning π§Ή
- Daily cleaning of C-PEC surfaces
- Weekly cleaning of floors, walls, ceilings in HD areas
- Use deactivating agents (sodium hypochlorite, peroxide) when appropriate
- Use disposable cleaning materials
- Document all cleaning activities
Example 1: Calculating BUD for Non-Sterile Compounding
Scenario: You're compounding a hydrocortisone 2% cream using:
- Hydrocortisone powder (expires in 2 years)
- Hydrophilic ointment base (expires in 1 year)
Question: What is the maximum BUD for this preparation stored at room temperature?
Solution:
| Step | Analysis | Result |
|---|---|---|
| 1 | Identify formulation type | Non-aqueous (cream base, no water added) |
| 2 | Check USP <795> table | Non-aqueous = 180 days maximum |
| 3 | Check ingredient expiration | Shortest = 1 year (base) |
| 4 | Apply rule | Use SHORTER of: 180 days OR time to expiration |
| 5 | Final BUD | 180 days (shorter than 1 year) |
Answer: The maximum BUD is 180 days from the date of compounding.
π‘ Key Takeaway: Non-aqueous formulations get the longest BUD (180 days), but this can be limited by ingredient expiration dates or stability data.
Example 2: Classifying Sterile Preparation Risk
Scenario A: Pharmacist adds 1 g cefazolin from a vial into a 50 mL minibag of NS for a single patient. Prepared in ISO 5 hood inside ISO 7 buffer room.
Analysis:
- β€3 sterile products? β (2 products: vial + bag)
- β€2 entries per container? β (1 entry into bag)
- Single patient? β
Classification: Category 1 (simple, low risk)
BUD at room temperature: 12 hours
Scenario B: Pharmacist prepares a total parenteral nutrition (TPN) bag combining:
- Amino acids 10%
- Dextrose 70%
- Lipid emulsion 20%
- Multiple electrolyte vials (sodium, potassium, calcium, etc.)
- Multivitamins
- Trace elements
Prepared in ISO 5 hood with proper environmental monitoring.
Analysis:
- β€3 sterile products? β (>10 ingredients)
- Multiple entries? β
- Complex mixing? β
Classification: Category 2 (medium risk, multiple ingredients)
BUD at room temperature (with ISO 5 documentation): 24 hours
π‘ Important: TPNs are classic Category 2 CSPs because they require combining many ingredients with extended manipulation time.
Example 3: Proper Garbing Sequence
Scenario: A pharmacy technician is about to compound sterile IV admixtures. What is the correct garbing sequence?
Correct Sequence:
| Order | Action | Location |
|---|---|---|
| 1 | Remove jewelry, watches | Before entering |
| 2 | Don shoe covers | Ante-area entry |
| 3 | Don hair/beard covers | Ante-area |
| 4 | Wash hands with soap and water | Ante-area sink |
| 5 | Don non-shedding gown | Ante-area |
| 6 | Don face mask | Ante-area |
| 7 | Enter buffer room | β Buffer room |
| 8 | Antiseptic hand cleansing (ABHR) | Buffer room |
| 9 | Don sterile gloves | Buffer room |
| 10 | Begin compounding | Inside PEC (ISO 5) |
β οΈ Common Error: Putting on gloves before entering the buffer room. Sterile gloves should be the LAST item donned, after antiseptic hand cleansing in the buffer room.
Example 4: Hazardous Drug Handling Decision
Scenario: A pharmacy receives prescriptions for:
- Cyclophosphamide 50 mg tablets (dispense 28 tablets)
- Finasteride 5 mg tablets (dispense 30 tablets)
- Doxorubicin 50 mg injection for compounding
Question: Which require hazardous drug precautions per USP <800>?
Analysis:
| Drug | HD Group | Activity | Precautions Needed? |
|---|---|---|---|
| Cyclophosphamide tablets | Group 1 (antineoplastic) | Counting/dispensing intact tablets | YES - Chemo gloves, gown, count on disposable pad |
| Finasteride tablets | Group 2 (reproductive risk) | Counting/dispensing intact tablets | YES (if handled by reproductive-age workers) - Standard gloves acceptable for intact tabs |
| Doxorubicin injection | Group 1 (antineoplastic) | Compounding/manipulating | YES - Full PPE, compound in BSC/CACI |
Answer: ALL three require precautions, but the level varies:
- Intact tablets: Minimal precautions (gloves)
- Compounding: Full engineering controls (C-PEC) and extensive PPE
π‘ Key Point: Even dispensing intact HD tablets requires basic precautions because tablets can chip or break, creating dust exposure.
β οΈ Common Mistakes to Avoid
Mistake #1: Confusing BUD with Expiration Date
ERROR: "This bottle expires in 2025, so my compounded preparation is good until then."
CORRECTION: BUD is based on USP standards (14/30/180 day rules for non-sterile, risk categories for sterile) AND ingredient expiration dates. Use the more conservative (shorter) date.
Mistake #2: Wrong Environmental Controls for Hazardous Drugs
ERROR: Compounding chemotherapy in a standard horizontal laminar flow hood.
CORRECTION: Hazardous drugs MUST be compounded in a containment device (BSC or CACI) with negative pressure and external venting. Regular hoods blow air at the operatorβdangerous with HDs!
β WRONG: Horizontal LAFW for HDs
Air ββββββββββ π¨ (operator exposed!)
HD particles blown at you
β
CORRECT: BSC for HDs
Air β (captured by HEPA)
π¨ β Barrier protects operator
Exhaust filtered and vented outside
Mistake #3: Incorrect Garbing Order
ERROR: Putting on sterile gloves in the ante-room, then touching the door to enter the buffer room.
CORRECTION: Sterile gloves are the LAST item donned, AFTER entering the buffer room and performing antiseptic hand cleansing. This prevents contamination from touching non-sterile surfaces.
Mistake #4: Inadequate HD PPE
ERROR: Using regular nitrile exam gloves when handling chemotherapy.
CORRECTION: Must use chemotherapy-tested gloves that meet ASTM D6978-05 standards. Regular gloves provide inadequate protection against cytotoxic drug permeation.
Mistake #5: Misclassifying Sterile Preparation Risk
ERROR: Calling a TPN "Category 1" because it's for one patient.
CORRECTION: Category depends on complexity, not just patient number. TPNs are Category 2 due to multiple ingredients (>3 products) and extended compounding time, even for a single patient.
Mistake #6: Forgetting Media Fill Testing
ERROR: Training staff on aseptic technique through demonstration only, without competency testing.
CORRECTION: USP <797> REQUIRES initial and ongoing media fill testing (process simulation with growth medium). Must pass 3 consecutive media fills initially, then annually (or semi-annually for high risk).
π§ Memory Aids and Mnemonics
The "3 USP C-Standards"
- USP <7-9-5>: Non-Sterile (7+9+5 = 21 = age you can drink = oral meds)
- USP <7-9-7>: Sterile (797 = "seven-ninety-SEVEN" = needles look like 7)
- USP <8-0-0>: Hazardous (800 = big number = big danger)
BUD Quick Reference: "14-30-180"
- 14: Water-based oral ("14 days to drink it")
- 30: Water-based topical ("30 days to rub it")
- 180: No water ("180 = half of 360 degrees = half a year")
Garbing Order: "Shoes Head Hands Gown β Go β Mask Hands Gloves"
S-H-H-G (ante-room) β Go (enter buffer) β M-H-G (buffer room)
ISO Classes: "5-7-8" = Cleaner β Dirtier
- ISO 5: Inside the hood (5 fingers on one hand = primary)
- ISO 7: Buffer room (7 days in a week = secondary)
- ISO 8: Ante-room (8 legs on spider = outer area)
π Key Takeaways
π Quick Reference Card: USP Compounding Standards
| Standard | Scope | Key Requirement | Critical Safety Point |
|---|---|---|---|
| USP <795> | Non-sterile compounding | BUD: 14/30/180 days based on formulation | Water = shorter stability |
| USP <797> | Sterile compounding | Risk categories (1/2/3) determine BUD | Media fill testing required for competency |
| USP <800> | Hazardous drugs | C-PEC (BSC/CACI) with negative pressure | Containment prevents staff exposure |
Environmental Controls Hierarchy:
- ISO Class 5 (PEC/C-PEC) = Where compounding happens
- ISO Class 7 (Buffer room) = Contains the PEC
- ISO Class 8 (Ante-room) = Garbing and hand hygiene
PPE Levels:
- Non-sterile: Gloves, lab coat
- Sterile: Full garbing (hair cover, gown, mask, sterile gloves)
- Hazardous: Chemo gloves (double for compounding), gown, face/eye protection
Documentation Essentials:
- Master formulation record (recipe)
- Compounding record (batch-specific log)
- Cleaning/maintenance logs
- Personnel training and competency records
π Further Study
USP Official Standards: www.usp.org/compounding - Access official USP chapter texts and updates
NIOSH List of Hazardous Drugs: www.cdc.gov/niosh/topics/antineoplastic/ - Current list of hazardous drugs in healthcare settings
FDA Compounding Guidance: www.fda.gov/drugs/human-drug-compounding - Regulatory perspective on compounding pharmacy practice
π― You now have the foundation to tackle NAPLEX questions on compounding standards! Remember: These aren't just test topicsβthey're the practices that keep patients and healthcare workers safe every single day.